Skip to main content
SpringerLink
Log in

The bridging function of clinical pharmacology

  • Editorial
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. WHO Study Group (1970) Clinical pharmacology, scope, organisation, training. WHO Technical Report Series no. 446. WHO, Geneva

    Google Scholar 

  2. Anonymous (1993) European association of clinical pharmacology and therapeutics. Br J Clin Pharmacol 36:183–184

    Google Scholar 

  3. Breckenridge A (1995) Clinical pharmacology and therapeutics. Br Med J 310:377–380

    CAS  Google Scholar 

  4. Sjöqvist F (1999) The past, present and future of clinical pharmacology. Eur J Clin Pharmacol 55:553–557

    Article  PubMed  Google Scholar 

  5. Honig P (2007) The value and future of clinical pharmacology. Clin Pharmacol Ther 81:17–18

    Article  PubMed  CAS  Google Scholar 

  6. Shenfield GM (2001) The many essential interfaces of clinical pharmacology. Clin Exp Pharmacol Physiol 28:887–890

    Article  PubMed  CAS  Google Scholar 

  7. FitzGerald GA (2007) Clinical pharmacology or translational medicine and therapeutics: reinvent or rebrand and expand? Clin Pharmacol Ther 81:19–20

    Article  PubMed  CAS  Google Scholar 

  8. Caskey CT (2007) The drug development crisis: efficiency and safety. Annu Rev Med 58:1–16

    Article  PubMed  CAS  Google Scholar 

  9. Sibille M, Donazzolo Y, Leccoz F et al (2006) After the London tragedy, is it still possible to consider Phase I is safe? Br J Clin Pharmacol 62:502–503

    Article  PubMed  Google Scholar 

  10. Giacomini K, Krauss RM, Roden DM, Eichelbaum M, Hayden MR (2007) When good drugs go bad. Nature 446:975–977

    Article  PubMed  CAS  Google Scholar 

  11. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling A-K, Avorn J (2002) Admissions caused by drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmcol 58:285–291

    Article  Google Scholar 

  12. Howard RL, Avery AJ, Slavenburg S et al (2007) Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 63:136–147

    Article  PubMed  CAS  Google Scholar 

  13. Perlis RH (2007) Cytochrome P450 genotyping and antidepressants. An imperfect measure of a modest predictor of response to antidepressants may not be ready for clinical application. Br J Med J 334:759

    Article  Google Scholar 

  14. Sjöqvist F, Eliasson E (2007) The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants. Clin Pharmacol Ther 81:899–902

    Article  PubMed  Google Scholar 

  15. Klotz U (2005) Reassessment of the benefit/risk-ratio of selective COX-2-inhibitors. Swiss Med Wkly 135:166–168

    PubMed  Google Scholar 

  16. Henry D, McGettigan P (2007) Selective COX-2 inhibitors: a promise unfulfilled? Gastroenterology 132:790–794

    Article  PubMed  CAS  Google Scholar 

  17. Maisel WH (2007) Unanswered questions—drug-eluting stents and the risk of late thrombosis. N Engl J Med 356:981–984

    Article  PubMed  CAS  Google Scholar 

  18. Curfman GD, Morrissey S, Jarcho JA, Drazen JM (2007) Drug-eluting coronary stents promise and uncertainty. N Engl J Med 356:1059–1060

    Article  PubMed  CAS  Google Scholar 

  19. Harrington RA, Ohman EM (2007) The enigma of drug-eluting stents. JAMA 297:2028–2030

    Article  PubMed  CAS  Google Scholar 

  20. Hecht F, Hecht BK, Sandberg AA (1998) The journal “impact factor”: a misnamed, misleading, misused measure. Cancer Genet Cytogenet 104:77–81

    Article  PubMed  CAS  Google Scholar 

  21. Wallin JA (2005) Bibliometric methods: pitfalls and possibilities. Basic Clin Pharmacol Toxicol 97:261–275

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany

    Ulrich Klotz

  2. University of Tübingen, Tübingen, Germany

    Ulrich Klotz

Authors
  1. Ulrich Klotz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Klotz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klotz, U. The bridging function of clinical pharmacology. Eur J Clin Pharmacol 63, 817–819 (2007). https://doi.org/10.1007/s00228-007-0347-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-007-0347-8

Search

Navigation